LOS ANGELES (KABC) -- New technology that's allowing doctors to pinpoint prostate cancer long before it becomes a threat is now widely available. A former firefighter mentioned how this new imaging ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Treat or observe? Dr. Joseph Renzulli of Yale School of Medicine shares how he assesses and counsels elderly patients referred for treatment because of elevated PSA levels. (2:44) Fighting Fatigue in ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about the role of PSMA-PET Imaging versus PSA. Prostate specific antigen (PSA) is a ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

Visual Abstract. Overall survival for patients treated with salvage radiotherapy: real world data from an entire country. A patient with biochemical recurrence after radical prostatectomy and no ...

Dr. Wallen: When the prostate cancer is only in the prostate and hasn't spread elsewhere, the standard of care treatments are surgery, radiation, or monitoring, which is called active surveillance.

A new phase 3 trial reveals that combining enzalutamide and leuprolide significantly improves overall survival for men with ...

A multicentre study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph’s Health Care London (Lawson), and University Health Network (UHN) has ...

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...